
Keywords: (cc)RCC, (clear cell) renal cell carcinoma; FDA, Food and Drug Administration; IFN-α, interferon alpha; VHL, Von Hippel–Lindau; HIF, hypoxia inducible factor; IL, interleukin; VEGF, vascular endothelial growth factor; VEGFR, VEGF receptor; PDGF, platelet-